Cambridge dominates women’s healthcare leadership rankings
Cambridge supplies almost a third of the 50 female leaders in UK healthcare businesses according to the 2017 BioBeat report released tomorrow.
The life science cluster provides 14 of the influencers named in the new edition of the annual report by the Cambridge-based innovation platform for healthcare entrepreneurs and leaders.
The report, entitled '50 Movers and Shakers in BioBusiness 2017’, celebrates how women are driving innovation in the UK healthcare industry, and comes within weeks of the Government announcing that the UK should improve its speed of adoption and the overall uptake of innovative medicines, devices and digital products by 2023.
The report emphasises how diversity of thinking is critical to the success of the sector in the UK.
BioBeat’s partners are Cambridge Judge Business School’s Entrepreneurship Centre and the Innovation Forum.
BioBeat Founder Miranda Weston-Smith says: “Women are transforming the pace, scale and ambition of what we can do in responding to global health challenges.
“ I am so excited to present 50 Movers and Shakers in BioBusiness 2017 – they are outstanding innovators and leaders who are giving us all a healthier world.”
Nikki Yates, senior VP, UK & Ireland Pharmaceuticals, GSK introduced the report and comments: “Diversity of talent is critical to life sciences and it is great to see the contribution these women are making. 50 Movers and Shakers in BioBusiness 2017 celebrates leaders whose dedication is about innovation in the healthcare business.
“It is fantastic to see that these are female leaders, and that they are recognised for the progress they have made over the past year.”
The 14 local players in the report are: Jean Abraham, University of Cambridge; Sarra Achouri, CamBioScience; Oriane Chausiaux, Heartfelt Technologies; Jane Dancer, F-star; Anne Dobrée, Cambridge Enterprise Seed Funds; Jasmin Fisher, University of Cambridge & Microsoft Research; Professor Rebecca Fitzgerald, University of Cambridge & Addenbrooke’s NHS Trust; Eleanor Fung, AstraZeneca; Alexandra Grigore, Simprints; Prof. Joanne Hackett, University of Cambridge; Karen Livingstone, Eastern Academic Health Science Network; Serena Scollen, ELIXIR; Ruchi Sharma, Stemnovate; Laura Taylor, Congenica.
• PHOTOGRAPH SHOWS: Miranda Weston Smith